Authors:
SHERWOOD JE
YOUNG S
SELIG W
SCHILLING A
KREUTNER W
EGAN RW
CHAPMAN RW
Citation: Je. Sherwood et al., A METHOD TO MEASURE DUAL NK1 NK2-ANTAGONIST ACTIVITY IN DOGS/, Journal of pharmacological and toxicological methods, 39(2), 1998, pp. 97-101
Citation: Mw. Smith et al., MITOCHONDRIAL-DNA ANALYSIS OF ATLANTIC COAST, CHESAPEAKE BAY, AND DELAWARE BAY POPULATIONS OF THE TELEOST FUNDULUS-HETEROCLITUS INDICATES TEMPORALLY UNSTABLE DISTRIBUTIONS OVER GEOLOGIC TIME, Molecular marine biology and biotechnology, 7(2), 1998, pp. 79-87
Authors:
STELTS D
EGAN RW
FALCONE A
GARLISI CG
GLEICH GJ
KREUTNER W
KUNG TT
NAHREBNE DK
CHAPMAN RW
MINNICOZZI M
Citation: D. Stelts et al., EOSINOPHILS RETAIN THEIR GRANULE MAJOR BASIC-PROTEIN IN A MURINE MODEL OF ALLERGIC PULMONARY INFLAMMATION, American journal of respiratory cell and molecular biology, 18(4), 1998, pp. 463-470
Citation: Ao. Ball et al., CHARACTERIZATION OF (GT)(N) MICROSATELLITES FROM NATIVE WHITE SHRIMP (PENAEUS-SETIFERUS), Molecular ecology, 7(9), 1998, pp. 1251-1253
Citation: Dc. Bolser et al., INFLUENCE OF CENTRALLY-ACTIVE ANTITUSSIVE DRUGS ON THE COUGH MOTOR PATTERN - IMPLICATIONS FOR THE FUNCTIONAL-ORGANIZATION OF THE CENTRAL COUGH NETWORK, The FASEB journal, 12(4), 1998, pp. 2893-2893
Authors:
MITCHELL SA
SPURKLAND A
BOBERG K
CHAPMAN RW
FLEMING KA
SCHRUMPF E
Citation: Sa. Mitchell et al., IS THE 308-POLYMORPHISM IN THE TUMOR-NECROSIS-FACTOR(ALPHA) (TNF-ALPHA) PROMOTER REGION A MARKER OF DISEASE SUSCEPTIBILITY IN EUROPEAN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC), Hepatology, 28(4), 1998, pp. 302-302
Authors:
MITCHELL SA
THYSSEN M
MITCHELL M
ORCHARD TR
JEWELL DP
FLEMING KA
CHAPMAN RW
Citation: Sa. Mitchell et al., CIGARETTE-SMOKING, APPENDECTOMY AND TONSILLECTOMY AS RISK-FACTORS FORTHE DEVELOPMENT OF PRIMARY SCLEROSING CHOLANGITIS (PSC) - A CASE-CONTROL STUDY, Hepatology, 28(4), 1998, pp. 1135-1135
Authors:
CAMERON BJ
BANSI DS
ALI R
CHAPMAN RW
FLEMING KA
Citation: Bj. Cameron et al., CHARACTERIZATION OF THE ANTIGEN FOR THE ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SPECIFIC FOR PRIMARY SCLEROSING CHOLANGITIS, Gut, 42, 1998, pp. 345-345
Authors:
CAMERON BJ
BANSI DS
ALI R
CHAPMAN RW
FLEMING KA
Citation: Bj. Cameron et al., CHARACTERIZATION OF THE ANTIGEN FOR THE ANTINEUTROPHIL CYTOPLASMIC ANTIBODY SPECIFIC FOR PRIMARY SCLEROSING CHOLANGITIS (PSC) ULCERATIVE-COLITIS (UC), Gastroenterology, 114(4), 1998, pp. 81-81
Citation: J. Shanahan et al., LIVER-CELL PROLIFERATION IN PRIMARY SCLEROSING CHOLANGITIS (PSC), AS ASSESSED BY ANTI-KI-67 LABELING, Gastroenterology, 114(4), 1998, pp. 583-583
Authors:
HEY JA
ASLANIAN R
BOLSER DC
CHAPMAN RW
EGAN RW
RIZZO CA
SHIH NY
FERNANDEZ X
MCLEOD RL
WEST R
KREUTNER W
Citation: Ja. Hey et al., STUDIES ON THE PHARMACOLOGY OF THE NOVEL HISTAMINE H-3 RECEPTOR AGONIST SCH-50971, Arzneimittel-Forschung, 48(9), 1998, pp. 881-888
Authors:
CHAPMAN RW
SEHRING SJ
GARLISI CG
FALCONE A
KUNG TT
STELTS D
MINNICOZZI M
JONES H
UMLAND S
EGAN RW
KREUTNER W
Citation: Rw. Chapman et al., ANTIINFLAMMATORY ACTIVITY OF INHALED MOMETASONE FUROATE IN ALLERGIC MICE, Arzneimittel-Forschung, 48(4), 1998, pp. 384-391
Citation: Mp. Small et Rw. Chapman, INTRASPECIFIC VARIATION IN THE 16S RIBOSOMAL GENE OF CRASSOSTREA-VIRGINICA, Molecular marine biology and biotechnology, 6(3), 1997, pp. 189-196
Authors:
FEDER LS
STELTS D
CHAPMAN RW
MANFRA D
CRAWLEY Y
JONES H
MINNICOZZI M
FERNANDEZ X
PASTER T
EGAN RW
KREUTNER W
KUNG TT
Citation: Ls. Feder et al., ROLE OF NITRIC-OXIDE ON EOSINOPHILIC LUNG INFLAMMATION IN ALLERGIC MICE, American journal of respiratory cell and molecular biology, 17(4), 1997, pp. 436-442
Authors:
CHRISTIE JML
DIKE AE
MITCHELL SA
KURTZ JB
TEO C
ROSENBERG W
FLEMING K
CHAPMAN RW
Citation: Jml. Christie et al., INCIDENCE AND OUTCOME OF HEPATITIS-C INFECTION IN BLOOD PRODUCT RECIPIENTS - EXPERIENCE OF THE OXFORD BLOOD CENTER WITHIN THE NATIONAL HCV LOOKBACK PROGRAM, Hepatology, 26(4), 1997, pp. 66-66
Authors:
MITCHELL SA
BANSI D
CHRISTIE J
FLEMING KA
CHAPMAN RW
Citation: Sa. Mitchell et al., DOWN-REGULATION OF INTERFERON-GAMMA AND UP-REGULATION OF INTERLEUKIN-10 BY URSODEOXYCHOLIC ACID (UDCA) IN PRIMARY SCLEROSING CHOLANGITIS (PSC), Hepatology, 26(4), 1997, pp. 814-814
Authors:
EGAN RW
WANG P
GARLISI C
MAUSER P
CHAPMAN RW
KREUTNER W
UMLAND SP
KUNG TT
Citation: Rw. Egan et al., MECHANISM OF EXTENDED DURATION OF ANTI-IL-5 ANTIBODIES AGAINST PULMONARY EOSINOPHILIA, Journal of allergy and clinical immunology, 99(1), 1997, pp. 496-496